Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in COVID-19
NCT04425538Phase 2Completed
- Sponsor
- Tufts Medical Center
- Start
- Jun 2020
- Primary completion
- Jan 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of infliximab in coronavirus disease 2019 (COVID-19), sponsored by Tufts Medical Center. Started Jun 2020; status: completed.
02
Drugs
infliximab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04425538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04425538.